Target intelligence / Profile preview

Human papillomavirus type 31 (HPV-31)

Target
HPV-31
Molecular classification
Other (virus), Papillomaviridae family, Alphapapillomavirus, species group alpha-9
01

Overview

Human papillomavirus type 31 (HPV-31) is a non-enveloped, double-stranded DNA virus in the Papillomaviridae family, closely related to HPV-16 and classified in Alphapapillomavirus, species alpha-9. Like other high-risk HPVs, it infects mucosal keratinocytes and is implicated in cervical intraepithelial neoplasia and cancer, with viral oncoproteins E6 and E7 playing a central role in disrupting cell cycle regulation by targeting host proteins such as p53 and pRb[3][2][1][4]. HPV-31 is one of the most frequent high-risk HPV types after HPV-16 and HPV-18 in cervical pathology. Detection is primarily via molecular diagnostics that identify viral DNA or expression of viral oncogenes.

Other names
Human papilloma virus 31HPV31HPV type 31
02

Mechanism of action

Not applicable (HPV-31 is not a druggable protein or receptor; its viral oncoproteins E6 and E7 are responsible for subverting tumor suppressor functions)

03

Biological functions

InfectionCell proliferation (by action of its oncoproteins)Cell cycle dysregulation
04

Disease associations

CancerInfection (notably cervical, anogenital, and oropharyngeal pre-cancer and cancer)
05

Safety considerations

Not applicable (as a virus, but vaccine safety is monitored; E6/E7-related oncogenic risk to humans)
06

Interacting drugs

None (direct antiviral drugs specific to HPV-31 are not established; however, prophylactic vaccines may prevent infection)
07

Biomarkers

HPV-31 DNA or mRNA in tissueE6/E7 expression

Beyond the preview

Go deeper on Human papillomavirus type 31 (HPV-31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 31 (HPV-31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call